Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2003
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630305 Compositions and methods for the therapy and diagnosis of prostate cancer
10/07/2003US6630302 Isolating DNA encoding ribosomal RNA; digesting with restriction enzymes, separating the fragments and comparing the signature bands of the digestion product with a control
10/07/2003US6630169 Particulate delivery systems and methods of use
10/07/2003US6630161 Stable oil in water emulsion; vaccine; squalene, PLURONIC, egg phosphatidyl choline, glycerol, alpha tocopherol
10/07/2003US6630146 Candida albicans phosphomannan complex as a vaccine
10/07/2003US6630144 Monoclonal antibodies to Ebola glycoprotein
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080839A2 Antigen fragments for the diagnosis of toxoplasma gondii
10/02/2003WO2003080837A1 Production of recombinant che a 1 allergen from chenopodium album and system of isolating and purifying same
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080800A2 Prevention and treatment of disease using angiogenesis-and/or tumor antigens
10/02/2003WO2003080799A2 Polymorphic repetitive sequences in chlamydiae and uses thereof
10/02/2003WO2003080792A2 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment
10/02/2003WO2003080678A1 Modified saccharides having improved stability in water
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080665A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003WO2003080658A1 Novel allergen
10/02/2003WO2003080654A2 Helicobacter flagellar, motility polypeptides
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080117A1 Methods for treating chronic obstructive pulmonary disease (copd)
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080114A2 Imidazoquinoline adjuvants for vaccines
10/02/2003WO2003080113A1 Mucosal immune vaccine for periodontal diseases
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080111A2 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080104A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003WO2003079995A2 Neisseria mutants, lipooligosaccharides and immunogenic compositions
10/02/2003WO2003079978A2 Protease activity of thrombin inhibits angiogenesis
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079968A2 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
10/02/2003WO2003079792A1 Methods and compositions for vaccination against or involving enterobacteriaceae bacteria
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003061629A3 Dna dosage forms
10/02/2003WO2003061577A3 Polyalkylene glycol with moiety for conjugating biologically active compound
10/02/2003WO2003049765A3 Enveloped virus vaccine and method for production
10/02/2003WO2003048299A3 Novel spore wall proteins and genes from microsporidia
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003031599A3 Live attenuated salmonella strains for producing vaccines
10/02/2003WO2003020767A3 Antibodies against caspase-8, their preparation and use
10/02/2003WO2003013593A3 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
10/02/2003WO2003010194A3 Meningococcus adhesins nada, app and orf 40
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2003006665A8 Lawsonia intracellularis
10/02/2003WO2002099056A3 C22c7orfs as modifiers of the p53 pathway and methods of use
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002090382A3 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
10/02/2003WO2002085405A3 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF$g(a)
10/02/2003WO2002081712A3 Artificial chromosomes comprising ehv sequences
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002057419A3 Protein-protein interactions
10/02/2003WO2002044197A3 Cytokine receptor binding peptides
10/02/2003WO2002042432A3 Epothilone resistant cell lines
10/02/2003WO2002041763A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/02/2003WO2002036748A3 Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells
10/02/2003WO2002036614A3 Peptides for use in the treatment of alzheimer's disease
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001086307A3 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187227 Solid phase synthesis
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187221 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
10/02/2003US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187189 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187184 Viral peptide for use in diagnosis and treatment of liver disorders; genetic vaccines
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
10/02/2003US20030186921 Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
10/02/2003US20030186919 Regulation of human sodium-dependent monoamine transporter
10/02/2003US20030186907 Endometrial function
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186849 Modified peptides and their use for the treatment of autoimmune diseases
10/02/2003US20030186848 Recombinant iron uptake proteins
10/02/2003US20030186431 Rabbit hemorrhagic disease vaccine and antigens
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186384 Comprises enzyme complex formed from proteases for modulating apoptosis and treating tumor, allergenic, autoimmune diseases and inflammatory diseases
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186364 For producing vaccines for the prevention or attenuation of infection by Staphylococcus
10/02/2003US20030186355 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
10/02/2003US20030186340 Amino acid sequences for use as diagnostic markers in bioassays; immunohistochemistry